Relief for GSK as Tesaro’s Zejula hits the mark in ovarian c...

GSK makes CRISPR play, funding Doudna lab in California

GlaxoSmithKline has forged an alliance with two leading CRISPR researchers that will see the creation of a new genomics research lab at the University of California.

Novartis builds case for asthma drugs to challenge GSK

Novartis has positive data for a two-drug asthma regimen that forms the backbone of its efforts to take on rival GlaxoSmithKline in the respiratory market.

Trial could unlock asthma use for GSK’s Trelegy

GlaxoSmithKline CEO Emma Walmsley has been predicting big things for respiratory triple therapy Trelegy in the next couple of years and has new data that could open up a new market.

Shingles vaccine boosts GSK as generic Advair bites

GSK’s first quarter sales beat estimates, helped along by shingles vaccine Shingrix and partly offsetting the effect of declining Advair sales.

FDA approves first treatment for children with lupus

The US FDA has approved GSK’s Benlysta (belimumab) intravenous infusion for the treatment of children with lupus.